Leukapheresis Market Size by Type (Leukapheresis Devices and Leukapheresis Disposables), By Application (Research Applications and Therapeutic Applications), By End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Blood Component Providers and Blood Centres and Hospitals and Transfusion Centers), By Region (North America, Europe, Asia-Pacific, Rest of the World), Market Analysis Report, Forecast 2023-2028
The Leukapheresis Market is expected to be around US$ 130 million by 2028 at a CAGR of 8.2% in the given forecast period.
COVID-19 Impact Analysis Report
"Get Latest Updated Reports as per the COVID-19 Impact"
Infopedia: Access Our All Reports Online at Affordable Price
CLICK HEREMARKET SNAPSHOT
Major Players
Study period:
Fastest Growing Market:
2023-2028
APAC
Base Year:
Largest Market:
2022
North America
CAGR:
8
REPORT DESCRIPTION
The Leukapheresis Market is expected to be around US$ 130 million by 2028 at a CAGR of 8.2% in the given forecast period.
The global leukapheresis market is likely to be driven by few factors prevailing in the industry. Some of these factors are increasing number of blood donations, and escalating demand for leukopaks. In addition, the growth of leukapheresis market is accelerated by surging demand for leukopaks in the development of cell-based therapies. Also, the prevalence of leukemia cancer has risen considerably in the past few years which is anticipated to propel the leukapheresis market globally. The increasing number of trauma cases and incidence of diseases are projected to promote the growth of leukapheresis market during the forecast period. Furthermore, the increasing investments by the government and rising competition among the key players are estimated to catalyze the market growth.
The global Leukapheresis market is segregated on the basis of Type as Leukapheresis Devices and Leukapheresis Disposables. Based on Application the global Leukapheresis market is segmented in Research Applications and Therapeutic Applications. Based on End User the global Leukapheresis market is segmented in Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Blood Component Providers and Blood Centres and Hospitals and Transfusion Centers.
The global Leukapheresis market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Leukapheresis market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Allcells, LLC, Asahi Kasei Corporation, Beijing Zksk Technology Co. Ltd., Bioivt, Caltag Medsystems Limited, Charles River Laboratories International, Inc., Discovery Life Sciences, Fresenius Se & Co. Kgaa, Guangzhou Daji Medical Science and Technology Co. Ltd., Haemonetics Corporation, Intelligent Tissue Group, Lonza Group Ag, Macopharma Sa, Medica Spa., Miltenyi Biotec, Precision for Medicine, Inc., and others are among the major players in the global Leukapheresis market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Leukapheresis Market has been segmented as below:
Leukapheresis Market, By Type
Leukapheresis Market, By Application
Leukapheresis Market, By Category
Leukapheresis Market, By Region
Leukapheresis Market, By Company
The report covers:
Report Scope:
The global Leukapheresis market report scope includes detailed study covering underlying factors influencing the industry trends. The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Leukapheresis market share. Major industry players with significant revenue share include Allcells, LLC, Asahi Kasei Corporation, Beijing Zksk Technology Co. Ltd., Bioivt, Caltag Medsystems Limited, Charles River Laboratories International, Inc., Discovery Life Sciences, Fresenius Se & Co. Kgaa, Guangzhou Daji Medical Science and Technology Co. Ltd., Haemonetics Corporation, Intelligent Tissue Group, Lonza Group Ag, Macopharma Sa, Medica Spa., Miltenyi Biotec, Precision for Medicine, Inc., and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations.
Below are our New Reports :-
Digital Health Monitoring Market
1. Introduction
1.1. Key Points
1.2. Report Description
1.3. Markets Covered
1.4. Stakeholders
2. Research Methodology
2.1. Research Scope
2.2. Market Research Process
2.3. Research Data Analysis
2.3.1.1. Secondary Research
2.3.1.2. Primary Research
2.3.1.3. Models for Estimation
2.4. Market Size Estimation
2.4.1. Bottom-Up Approach- Segmental Market Analysis
2.4.2. Top-Down Approach- Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1. Introduction
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
4.2. Porter's Five Force Analysis
5. Leukapheresis Market, By Type
5.1. Introduction
5.2. Leukapheresis Devices
5.2.1. Market Overview
5.2.2. Market Size and Forecast
5.3. Leukapheresis Disposables
5.3.1. Market Overview
5.3.2. Market Size and Forecast
6. Leukapheresis Market, By Application
6.1. Introduction
6.2. Research Applications
6.2.1. Market Overview
6.2.2. Market Size and Forecast
6.3. Therapeutic Applications
6.3.1. Market Overview
6.3.2. Market Size and Forecast
7. Leukapheresis Market, By End User
7.1. Introduction
7.2. Pharmaceutical and Biotechnology Companies
7.2.1. Market Overview
7.2.2. Market Size and Forecast
7.3. Academic and Research Institutes
7.3.1. Market Overview
7.3.2. Market Size and Forecast
7.4. Blood Component Providers and Blood Centres
7.4.1. Market Overview
7.4.2. Market Size and Forecast
7.5. Hospitals and Transfusion Centers
7.5.1. Market Overview
7.5.2. Market Size and Forecast
8. Leukapheresis Market, By Geography
8.1. Introduction
8.2. North America
8.2.1. North America Leukapheresis, By Type
8.2.2. North America Leukapheresis, By Application
8.2.3. North America Leukapheresis, By End User
8.3. Europe
8.3.1. Europe Leukapheresis, By Type
8.3.2. Europe Leukapheresis, By Application
8.3.3. Europe Leukapheresis, By End User
8.4. Asia-Pacific
8.4.1. Asia-Pacific Leukapheresis, By Type
8.4.2. Asia-Pacific Leukapheresis, By Application
8.4.3. Asia-Pacific Leukapheresis, By End User
8.5. Rest of the World
8.5.1. Rest of the World Leukapheresis, By Type
8.5.2. Rest of the World Leukapheresis, By Application
8.5.3. Rest of the World Leukapheresis, By End User
9. Competitive Insights
9.1. Key Insights
9.2. Company Market Share Analysis
9.3. Strategic Outlook
9.3.1. Mergers & Acquisitions
9.3.2. New Product Developments
9.3.3. Portfolio/Production Capacity Expansions
9.3.4. Joint Ventures, Collaborations, Partnerships & Agreements
9.3.5. Others
10. Company Profiles
10.1. Allcells, LLC
10.1.1. Company Overview
10.1.2. Product/Service Landscape
10.1.3. Financial Overview
10.1.4. Recent Developments
10.2. Asahi Kasei Corporation
10.2.1. Company Overview
10.2.2. Product/Service Landscape
10.2.3. Financial Overview
10.2.4. Recent Developments
10.3. Beijing Zksk Technology Co. Ltd.
10.3.1. Company Overview
10.3.2. Product/Service Landscape
10.3.3. Financial Overview
10.3.4. Recent Developments
10.4. Bioivt
10.4.1. Company Overview
10.4.2. Product/Service Landscape
10.4.3. Financial Overview
10.4.4. Recent Developments
10.5. Caltag Medsystems Limited
10.5.1. Company Overview
10.5.2. Product/Service Landscape
10.5.3. Financial Overview
10.5.4. Recent Developments
10.6. Charles River Laboratories International, Inc.
10.6.1. Company Overview
10.6.2. Product/Service Landscape
10.6.3. Financial Overview
10.6.4. Recent Developments
10.7. Discovery Life Sciences
10.7.1. Company Overview
10.7.2. Product/Service Landscape
10.7.3. Financial Overview
10.7.4. Recent Developments
10.8. Fresenius Se & Co. Kgaa
10.8.1. Company Overview
10.8.2. Product/Service Landscape
10.8.3. Financial Overview
10.8.4. Recent Developments
10.9. Guangzhou Daji Medical Science and Technology Co. Ltd.
10.9.1. Company Overview
10.9.2. Product/Service Landscape
10.9.3. Financial Overview
10.9.4. Recent Developments
10.10. Haemonetics Corporation
10.10.1. Company Overview
10.10.2. Product/Service Landscape
10.10.3. Financial Overview
10.10.4. Recent Developments
10.11. Intelligent Tissue Group
10.11.1. Company Overview
10.11.2. Product/Service Landscape
10.11.3. Financial Overview
10.11.4. Recent Developments
10.12. Lonza Group Ag
10.12.1. Company Overview
10.12.2. Product/Service Landscape
10.12.3. Financial Overview
10.12.4. Recent Developments
10.13. Macopharma Sa
10.13.1. Company Overview
10.13.2. Product/Service Landscape
10.13.3. Financial Overview
10.13.4. Recent Developments
10.14. Medica Spa.
10.14.1. Company Overview
10.14.2. Product/Service Landscape
10.14.3. Financial Overview
10.14.4. Recent Developments
10.15. Miltenyi Biotec
10.15.1. Company Overview
10.15.2. Product/Service Landscape
10.15.3. Financial Overview
10.15.4. Recent Developments
10.16. Precision for Medicine, Inc.
10.16.1. Company Overview
10.16.2. Product/Service Landscape
10.16.3. Financial Overview
10.16.4. Recent Developments
The Leukapheresis Market has been segmented as below:
Leukapheresis Market, By Type
Leukapheresis Market, By Application
Leukapheresis Market, By Category
Leukapheresis Market, By Region
Leukapheresis Market, By Company
Got a question? We've got answers. If you have some other questions, see our support center.
© 2020 COPYRIGHT : MARKET RESEARCH ENGINE